Hypoxia and Inflammatory Injury in Human Renovascular Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 21, 2014

Primary Completion Date

September 25, 2020

Study Completion Date

September 25, 2020

Conditions
Renal Artery StenosisIschemic NephropathyRenovascular DiseaseChronic Kidney Disease
Interventions
DRUG

Mesenchymal stem cell

Intra-arterial infusion of the single-dose MSC

PROCEDURE

Mesenchymal stem cell delivery with stent placement

Intra-arterial stent placement after Mesenchymal stem cell infusion

Trial Locations (3)

35294

University of Alabama, Birmingham

39216

University of Mississippi, Jackson

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Mississippi Medical Center

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

Mayo Clinic

OTHER